Shareholder commits to sell no more shares until after full year result.
NBR staff Tue, 23 Jun 2020
The biggest shareholder of medical products distributor Ebos Group has announced a further sell-down of its stake through a bookbuild run by Citigroup.
The process will sell 15 million Ebos shares held by Sybos Holdings at an underwritten price of $21.52, raising $322.8 million.
Ebos shares
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
